Friday, 10 August 2012

Newsbite: New Generic Version of Itraconazole Launched

The antifungal drug itraconazole was originally marketed as Sporanox by Janssen Pharmaceuticals and has been very useful in clinics for its activity against Aspergillus as well as several other fungal infections. Janssens copyright expired some time ago, allowing other companies to manufacture their own versions of itraconazole. The latest company to do so and to be granted FDA approval in the US is Mylan.
more...

No comments:

Amazon Contextual Product Ads

Contact us at admin@aspergillus.org.uk